Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In the last ten years FDA made 0 decisions for Uoc (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families.
In 2025, Uoc reported engagement with 91 surgeons and other clinicians in the states MedaRep covers, worth $465K in consulting, speaking, meals and travel for its device products, the most in Florida ($86K to 20). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Florida ($86K, 20 engaged), Texas ($61K, 10 engaged), Colorado ($60K, 5 engaged), Pennsylvania ($58K, 3 engaged), New York ($48K, 8 engaged).